Transcriptional regulatory networks specify the interactions among regulatory genes and between regulatory genes and their target genes. Discovering transcriptional regulatory networks helps us to understand the underlying mechanism of complex cellular processes and responses. In this paper, we describe a causal inference approach for constructing transcriptional regulatory networks using gene expression data, promoter sequences and information on transcription factor binding sites. The method rst identies active transcription factors under each individual experiment using a feature selection approach similar to Bussemaker et al. (2001), Keles et al. (2002) and Conlon et al. (2003) . Transcription factors are viewed as 'treatments' and gene expression levels as 'responses'. For every transcription factor and gene pair, a marginal structural model is built to estimate the causal eect of the transcription factor on the expression level of the gene. The model parameters can be estimated using either the G-estimation procedure or the IPTW estimator. The p-value associated with the causal parameter in each of these models is used to measure how strongly a transcription factor regulates a gene. These results are further used to infer the overall regulatory network structures. We carried out simulations to assess the performance of our method in the estimation of a ctitious regulatory network. Our analysis of yeast data suggests that the method is capable of identifying signicant transcriptional regulatory interactions and the corresponding regulatory networks.
Introduction
Transcriptional regulatory networks specify the interactions among regulatory genes and between regulatory genes and their target genes. Discovering transcriptional regulatory networks is an important scientific task since it helps us to understand the underlying mechanism of complex cellular processes and responses.
There is a rich literature in methods for inferring regulatory networks. Lee et al. (2002) and Bar-Joseph et al. (2003) used the experiment-based genome-wide location analysis to investigate how yeast transcription factors (TF) bind to promoter sequences across genome, then constructed transcription factor-promoter binding networks to infer transcriptional regulatory networks. Location analysis experiments provide in vivo evidence of transcription factor binding to genes. However, physical binding does not directly imply transcriptional regulatory activities. Moreover, location analysis experiments are often restricted to a certain growth condition. As a result, transcription factor-promoter binding network structures specific to other growth conditions may not be observed.
As microarray data on gene expression programs become available, various statistical data mining tools have been devised for discovering (often more broadly defined) gene networks, for example, reverse engineering approaches (Somogyi et al., 1997; Liang et al., 1998; D'Haeseleer et al., 2000) , differential equations (Chen et al., 1999; D'Haeseleer et al., 1999) , Bayesian networks (Friedman et al., 2000; Yoo et al., 2002) , etc. These methods often require large number of time-course data or rely on very greedy computational strategies.
Some other computational methods attempt to integrate gene expression data, DNA sequences and functional annotations into a comprehensive framework for discovering transcriptional regulatory networks (Pilpel et al., 2001; Wang et al., 2002; Segal et al., 2003; Beer and Tavazoie, 2004) . These methods allow one to infer motif-to-gene or to some extent gene-to-gene regulatory networks.
Xing and van der Laan (2005) described a statistical approach for constructing transcriptional regulatory networks using gene expression, promoter sequence and transcription factor binding site data. This approach first identifies transcription factors that are significantly associated with changes in gene expression profile under each experiment condition, then estimates the strength with which a regulatory gene regulates a potential target gene, and finally averages evidence across experiments to infer the transcriptional regulatory network structures. This method employs a naive normal mixture model to estimate the strength with which a regulatory gene regulates a potential target gene. The normal mixture model is chosen for computational convenience. There are some concerns with the appropriateness of using a normal or other mixture models, e.g., the data may not appear to be normally distributed and consequently the model estimation may be poor. In addition, the mixture model is built on the transformed gene expression data for each transcription factor separately. There is not enough control for the possible confounding effects of other transcription factors on the estimated transcriptional regulatory interactions between the transcription factor under analysis and its potential target genes.
Here we describe an alternative approach based on causal inference methodology. We can view each gene as a subject and each transcription factor analogous to a 'treatment', which may have direct causal effects on the 'responses' (i.e., expression levels) of its target genes whose regulatory region is able to be bound by the transcription factor when it is active in an experiment. For genes whose regulatory region does not contain the transcription factor binding sites, there is no direct causal effect of the transcription factor on the expressions of those genes. More specifically, a 'treatment' variable is created for each transcription factor and coded into 1 when the transcription factor is active and 0 when the transcription factor is inactive in an experiment. Then for each experiment we will have a vector of 'treatments' associated with all the transcription factors, some of which may be active and some may be not. For different experiments, there will be different combinations of 'treatments' as the active or inactive status of the transcription factors can be different across experiments. The changes in the expression level of a gene across experiments are seen as results from different combinations of 'treatments' under different experiment conditions. It should be noted that here a 'treatment' is not a usual treatment as we see in a controlled clinical trial, which is known prior to study and highly manipulable. In a typical microarray gene expression experiment, the transcription factor activities may not be deliberately controlled at all or may be under only limited manipulation. To our purpose of constructing transcriptional regulatory networks, we will need to first estimate the activities of transcription factors in a experiment and treat the transcription factor as 'treatments' that are causally responsible for the changes in gene expression levels.
Under this framework, we describe in the next section a causal inference approach for constructing transcriptional regulatory networks using gene expression data, promoter sequences and transcription factor binding sites. The method estimates 'treatment' code associated with each transcription factor under each experiment condition, then builds a marginal structural model for each gene and transcription factor pair to model the causal effect of the transcription factor on the expression level of the gene. Methods for estimating the model and inferring regulatory network structures are described. We conduct simulation studies to assess the performance of the proposed method in the estimation of a fictitious regulatory network. The results are summarized in Section 3. In Section 4, we apply the method to the yeast data to study the yeast transcriptional regulatory network. We conclude with a discussion of the uses and limitations of our method in Section 5.
Method

A brief introduction to causal inference methods
In causal inference, one concerns with estimation of a causal effect (a parameter with a causal interpretation) of a variable that can be manipulated (e.g., a treatment) on an outcome of interest, possibly adjusted for other variables. Robins (1986 Robins ( , 1999a , Robins et al. (2000) and van der Laan and Robins (2002) described causal inference methods for estimating the average marginal causal effect of treatment A on outcome Y adjusted for covariates V ⊂ W , based on longitudinal data involving time-independent or time-dependent treatments. The marginal causal effects are defined using the concept of counterfactual. The counterfactual Y a represents the random variable Y one would have observed, if, possibly contrary to the fact, one would have 'assigned' A = a, where a ∈ A and A denotes a set of possible treatments.
For a point treatment study, which is a special case of longitudinal study, the observed data structure is O = (A, Y A , W ), where W is a set of baseline covariates. The full data structure is X = ((Y a : a ∈ A), W ), where Y a is the counterfactual. A marginal structural model (MSM) can be used to estimate the average marginal causal effect of A on Y (i.e., the effect of a on E(Y a |V )) adjusted for V ⊂ W as follows:
For example, we may specify a linear model like m(a, V |β) = β 0 +β 1 a+β v V , where β 0 is the intercept, β 1 is the parameter for the marginal causal effect, β v is a vector of regression coefficients, V is a subset of baseline covariates to be adjusted. Let ε a (β) = Y a − m (a, V |β) . Then E(ε a (β)|V ) = 0 for each a ∈ A. The estimation of causal parameter β 1 requires the assumption of no unobserved confounders, i.e., g(A|X) = g(A|W ), where g is a probability density (or mass) function, representing the treatment assignment mechanism. In other words, this assumption states that treatment A is conditionally independent of the counterfactual outcomes given W , i.e., A is randomized within each stratum of W . Let M = (M (1), . . . , M (K)) be a vector of DNA binding motifs, possibly of variable lengths, which correspond to the binding sites of K known transcription factors. Suppose we know the correspondence between a transcription factor k and its producer gene g(k), for k = 1, . . . , K.
Consider now a particular gene expression experiment. Let Y = (Y (j) : j = 1, . . . , J) be the observed gene expression vector. Given data of S, M and Y , we can estimate the set of transcription factors that are active under the experiment condition (where a transcription factor is 'active' refers to the situation in which the DNA binding site of the transcription factor is significantly associated with the changes in the genome-wide gene expression values), using linear regression with model selection or multiple testing procedures as described in Bussemaker et al. (2001) , Keles et al. (2002) , Conlon et al. (2003) and Xing and van der Laan (2005) . These procedures provide ways to transform single-experiment gene expression data (Y ), promoter sequences (S) and transcription factor binding sites (M ) into a vector of 'treatment' codes indicating which transcription factor is active or not in an experiment. Denote the 'treatment' vector by
where φ is a mapping function corresponding to a procedure used to estimate A, A(k) = 1 means the k-th transcription factor is active under the current experiment condition and A(k) = 0 otherwise. So, after having obtained this transformation, we define our data as (A, Y, S, M ). Now suppose we have a collection of n gene expression experiments under different conditions, possibly conducted for independent study purposes. We assume that we can view these n gene expression experiments as n i.i.d. draws from some population data generating distribution. Under this assumption, we have n i.i.d. observations (A i , Y i ), i = 1, . . . , n and fixed sequence data S and M .
A causal inference model
We view the data analogous to data from a point treatment study, where the 'treatment' is whether a transcription factor is active or not. Consider a nonparametric marginal structural model which estimates the causal effect of transcription factor k on gene expression j for each j = 1, . . . , J and k = 1, . . . , K.
Let (j, k) be given. We now define a counterfactual gene expression outcome Y a (j, k), which represents the expression level of gene j one would have observed if one had set/assigned A(k) = a, a ∈ {0, 1}. Here Y 0 (j, k) can be thought of as the expression of gene j one would have observed if one had knocked out gene g(k) (and thereby eliminating transcription factor k), or controlled transcription factor k to be inactive in the sense of binding and regulation, while Y 1 (j, k) can be thought of as the expression value of gene j one would have observed if one had controlled transcription factor k to be actively involved in binding and regulation under the experiment condition.
that is, G(k 1 , k 2 ) equals 1 if the binding site of transcription factor k 1 is contained in the promoter region of gene k 2 , and it equals 0 otherwise. Let
From this graph G we can obtain a K × K potential transcription factor connectivity matrix, denoted by
. . , K}, l = k and δ(k, l) = 0 be the sub-vector of A corresponding to all transcription factors which are not on the potential causal pathway from A(k) to Y (j), and are therefore potential confounders of A(k). We now think of the full data as
We link the observed data to this counterfactual data by the relation:
We assume there are no unmeasured confounders, in other words, A(k) is conditionally independent of the counterfactual gene expressions
If there would be variables affecting the absence/presence of transcription factor k (i.e., A(k)), which are not included in W (j, k), then this assumption could be violated. In addition, we assume the (j, k)-specific experimental treatment assignment assumption holds, which states that 0 < P (A(k) = 1 | W (j, k)) < 1 a.e. This now defines a nonparametric marginal structural model M(j, k) for the data structure O(j, k), and the parameter of interest is given by β 1 (j, k).
We consider a simple (j, k)-specific nonparametric marginal structural model as follows
where a ∈ {0, 1} and β 1 (j, k) is the causal parameter. The indicator function I(M (k) ⊂ S(j)) constrains the model to estimate the causal parameter only when there is a possible direct effect of transcription factor k on gene expression j.
We are interested in estimating the causal parameter β 1 (j, k) for every gene and every transcription factor. Several strategies have been proposed for the estimation of the marginal causal parameters: (1) the G-computation estimation procedure (Robins, 1986 (Robins, , 1987 , which requires the model for E F X (Y |A, W ) be correctly specified (where F X represents the full data distribution); (2) the inverse probability of treatment weighted (IPTW) estimation procedure (Robins, 1999a,b; Robins et al., 2000; van der Laan and Robins, 2002) , which requires the treatment mechanism (g(A|W )) be correctly specified; and (3) the double robust (DR) estimation procedure (Robins, 2000; van der Laan and Robins, 2002) , which requires either the model for E F X (Y |A, W ) or the model for g(A|W ) is correctly specified. Since our analysis involves large scale genomic data, we may use the Gcomputation estimator or the IPTW estimator for computational ease.
The G-Computation estimation procedure
Let P and P n denote the true and empirical data distribution, respectively. Since
Then the causal parameter
The G-Computation estimation requires us to assume a suitable model for E Y (j)|A(k) = a, W (j, k) . For simplicity, we may assume a linear model of the form as follows:
where γ is the coefficients and
We first estimate the model based on the observed data, that is,
using the above estimated model but using Z 1 and Z 0 instead of Z.
To estimate V ar(β 1 (j, k)), i.e., the variance of the estimated causal effect, we need to estimate the influence curve of the estimatorβ 1 (j, k). We describe the estimation procedure below. For notation convenience, we drop the index for j and k.
Let M(a, W |γ) be the true data generating model, and M(a, W |γ) be the empirically estimated model. Then we can write
β 1 is a consistent estimator for β 1 . Under regularity condition,β 1 − β 1 is asymptotically linear with influence curve being
Note IC(O i ) can be estimated by
and σ 2 can be estimated bŷ
http://biostats.bepress.com/ucbbiostat/paper169
The IPTW estimation procedure
The IPTW estimator is constructed by the following estimating function:
where h is a vector function of A and V , and g is a conditional distribution of A given W (i.e., treatment mechanism). It is shown that, under the assumption of no unobserved confounders (NUC) and the experimental treatment assignment (ETA) assumption, the above estimating function is unbiased for β, i.e., E(D h (O|β, g)) = 0 (Neugebauer and van der Laan, 2002).
As suggested by Robins (1999b) g (A|W ) . To estimate the weight, we need to model the treatment mechanism g(A|W ). For our particular problem, A is binary with A = 1 if the transcription factor under study is active and A = 0 otherwise. A convenient choice of the model for g(A|W ) is the logistic regression model, for example,
So, the estimated weight is wt i =ĝ
Inference on the regulatory network structures
After fitting the causal marginal structural model (1) for every gene and every transcription factor, we can obtain a J by K p-value matrix, P , whose element is defined by
The J by K transcriptional regulatory interaction matrix (B) can be estimated bŷ
where p is a user specified p-value threshold (e.g., p = 0.001).
NoteB jk = 1 may be interpreted as that the marginal causal effect of the k-th transcription factor on the j-th gene is significantly different from zero. Therefore, we infer that there is a transcriptional regulatory interaction between the k-th transcription factor and the j-th gene.
We then can use the methods described in Lee et al. (2002) and Xing and van der Laan (2005) to identify network motifs and assemble the overall regulatory network.
Simulation Studies
We conduct simulations to show how the proposed computational approach performs in re-constructing the underlying regulatory network structure. The parameter of interest is the transcriptional regulatory interaction matrix B, which may be regarded as a 2-dimensional representation of the underlying network. Note that B is constructed in simulation studies but not known in practice.
Constructing a fictitious regulatory network
We consider a fictitious transcriptional regulatory network consisting of 10 transcription factors and 90 genes. For simplicity, suppose that five of the transcription factors are inducers and the remaining five are repressors. Also suppose that one-third of the genes are regulated by at least one inducer but no repressors, another one-third regulated by at least one repressor but no inducers, and the remaining one-third regulated by none of the 10 transcription factors. We randomly construct a binary-valued transcriptional regulatory interaction matrix B, which satisfies the above condition.
Constructing a fictitious motif abundance matrix
Next we construct a fictitious motif abundance matrix X, which indicates the presence or absence of binding sites of the 10 fictitious transcription factors in the promoter sequences of each gene. Note that X is available in practice based on sequence data M and S. A necessary condition for the k-th transcription factor transcriptionally regulates the j-th gene is that the j-th gene must have at least one binding site for the k-th transcription factor in its promoter region. In other words, B jk = 1 implies that X jk = 1. It is also true that X jt = 0 implies that B jk = 0. However, when X jk = 1, B jk may be 1 or 0. We regard the situation that B jk = 0 and X jk = 1 (i.e. a transcription factor does not regulate a gene even though the gene promoter is abundant with binding sites of the transcription factor) as systematic noise in the motif abundance matrix.
We use the following rules to construct the motif abundance matrix X:
We consider three values for δ, i.e., δ = 0.10, 0.20, 0.30, representing different levels of systematic error in the motif abundance matrix X.
Simulating gene expression data for different conditions
Next we generate data that resemble the situation that we have a collection of n experiments. Each experiment is seen as a realization of certain part of the true underlying regulatory network.
To do so, for each i = 1, . . . , n, we draw a random subset τ (i) ⊆ {1, . . . , K}, with a random size |τ (i)| ∼ Uniform {3, . . . , 7}.
The fictitious gene expression data are generated using a multiple linear model as follows
where j indexes genes, i indexes experiments, k indexes transcription factors, β's are coefficients, j is the gene-specific random error, E( j ) = 0, and τ (i) is the set of transcription factors that are active under the i-th experiment.
For simplicity, we assume β 0 = 0, β t = (0. 25, 0.30, 0.35, 0.40, 0.45, -0.25, -0.30, -0.35, -0.40, -045) , and j = ∼ N (0, σ 2 ). We consider three values for σ, i.e., σ = 0.25, 0.50, 0.75, representing different levels of random errors in microarray measurements.
We estimateB based on the generated data and compute the overall error rate and false positive rate as defined in Section 3.4. We repeat the procedures 100 times and get average estimates of the error rates.
Error in estimation
To assess the error in estimation, we define the overall error rate (OER), the false positive rate (FPR) and the false negative rate (FNR) as follows to indicate the overall accuracy, node accuracy and node completeness respectively: 
Simulation results
The simulation results (using the IPTW estimation) are shown in Table  1 , where ∼ N (0, σ 2 ) with σ = 0.25, 0.5, 0.75 indicates increasing level of random error in gene expression measurements, and δ = 0.1, 0.2, 0.3 indicates increasing level of systematic error in the constructed motif abundance matrix X. Three sample sizes (n=50, 100, 200) are used.
We see that the all the OER, FPR and FNR increase as the systematic error increases and decrease as the sample size increases. The OER and FNR also increase as the random error increases. The FPR may also increase as the random error increases but the trend is not consistent. When the systematic error and random error are small and the sample size is moderately large, the overall error rate, the false positive rate and the false negative rate are reasonably small. In real world, we do not know the magnitude of the systematic error with respect to the relationship between motif abundance and transcriptional regulatory interaction. If the systematic error is very large, we would not expect some of the motif detection methods (Bussemaker et al., 2001; Keles et al., 2002; Conlon et al., 2003) to work well. Successful results from these studies imply that the assumption of a small or moderate systematic error may be realistic in real data analysis.
We apply our method to study the transcriptional regulatory network in S. Cerevisiae (budding yeast) based on analysis of a large collection of DNA microarray experiments.
Data
DNA microarray experiments
We collect 658 DNA microarray experiments on yeast gene expression programs under various conditions: 7 on diauxic shift (DeRisi et al., 1997) , 10 on sporulation , 60 on cell cycle (Spellman et al., 1998) , 4 on adaptive evolution (Ferea et al., 1999) , 173 on environmental stress (Gasch et al., 2000) , 6 on Copper regulation (Gross et al., 2000) , 300 on diverse mutations and chemical treatments (Hughes et al., 2000) , 8 on Pho metabolism (Ogawa et al., 2000) , 12 on SNF/SWI mutants (Sudarsanam et al., 2000) , 26 on FKH1 and FKH2 roles during cell cycle (Zhu et al., 2000) , and 52 on DNA damage (Gasch et al., 2001 ).
Prior to analysis, the data are normalized by subtracting the genomewise median for every experiment. In addition, the log 2 (ratios) are truncated by ± log 2 (20).
Promoter sequences
We extract promoter sequences of 700 bps in length in the upstream noncoding region [-700, -1] for 6136 ORFs using the SCPD database (Zhu and Zhang, 1999) .
Transcription factor binding sites
We collect known binding sites for 46 yeast transcription factors from SCPD (Zhu and Zhang, 1999) , TRANSFAC (Wingender et al., 1996) , and YPD of Incyte Proteome BioKnowledge Library (Hodges et al., 1999 ) (see Table 2 ).
Analysis results
Estimated transcriptional regulatory interactions
The estimated number of transcriptional regulatory interactions between transcription factors and genes is a function of cut-off value used. Table 3 shows the results at different cut-off levels.
[ Table 3 about here.]
In our analysis, we choose p = 0.001 as a threshold to infer the yeast transcriptional regulatory interaction. The estimated transcriptional regulatory interaction matrix is then used to find network motifs and network structures.
Network motifs
Network motifs are the simplest units of the network architecture, which suggest models for regulatory mechanism that can be tested. Lee et al. (2002) described six regulatory network motifs in terms of transcription factor binding (see Figure 1 ) and algorithms to find them. We redefine the network motifs in terms of transcriptional regulatory interaction as follows: (a) Auto-regulation motif, in which a regulator gene regulates its own expression; (b) Feed-forward loop motif, in which a master regulator regulates the second regulator and both regulate a common target gene; (c) Multi-component loop motif, in which regulator(1) regulates regulator(2), ..., regulator(n-1) regulates regulator(n), and regulator(n) regulates regulator(1), where n ≥ 2; (d) Single input motif, in which a single regulator uniquely regulates a set of target genes; (e) Multi-input motif, in which a set of regulators regulate a set of target genes together; and (f) Regulator chain motif, in which regulator(1) regulates regulator(2), ..., regulator(n-1) regulates regulator(n), where n ≥ 2 and the chain ends if regulator(n) does not directly regulate any other regulator that is not on the chain.
[ Figure 1 about here.] We used the algorithms described in Lee et al. (2002) and Xing and van der Laan (2005) to find interesting transcriptional regulatory network motifs. We found 6 auto-regulated genes, 37 feed-forward loops, 1 multicomponent loops, 26 single-input modules, 254 multi-input modules and 96 regulator chains, based on the estimated transcriptional regulatory interactions matrix for 46 transcription factors and 6136 genes, at a threshold of p = 0.001.
To assess the significance of the findings, we compared our results with those from Lee et al. (2002) . Our analysis involves 46 transcription factors, the analysis of Lee et al. (2002) involves 106 transcription factors. We have 33 transcription factors in common. However, since the presence of additional transcription factors affects the finding of almost all the network motifs, particularly the single-input and multi-input modules and regulator chains (a result of the network motif finding algorithm). So the comparison focuses on only auto-regulation motif and feed-forward loop motif.
[ Table 4 about here.] Table 4 lists genes that are likely to be autoregulated. At the threshold of p = 0.001, we found 6 regulator genes (out of 46) that may be autoregulated: ADR1, MIG1, NDT80, RAP1, ROX1 and TBP1. Among these, RAP1 was also identified as an autoregulated gene in Lee et al. (2002) , and NDT80 and ROX1 were computationally identified as autoregulated genes in Xing and van der Laan (2005) .
NDT80p functions at pachytene of yeast gametogenesis (sporulation) to activate transcription of a set of genes required for both meiotic division and gamete formation. There is evidence that NDT80p activates its own transcription through an upstream MSE consensus site Lindgren et al., 2000) .
The ROX1 gene encodes a heme-induced repressor of hypoxic genes in yeast. Experiments indicated that ROX1p is capable of binding to its own upstream region and represses its own expression (Deckert et al., 1995) . ROX1 was included in Lee et al. (2002) , but was not identified as autoregulated. At a less restrictive threshold level, STE12 and SWI4 are also found to be autoregulated, which were also identified as autoregulated genes in Lee et al. (2002) and Xing and van der Laan (2005) . However, we did not found literature support for ADR1, MIG1 and TBP1. Regulation mechanisms for these genes are not completely clear.
We found 37 feed-forward loops involving 23 transcription factors at the threshold level of p = 0.001. Among these, RAP1-HSF1 was also identified in Lee et al. (2002) . ADR1, LEU3, MIG1 and TBP1 seem to form a feed-forward loop with MSN4, as the same relationships were also found computationally in Xing and van der Laan (2005) .
Overall transcriptional regulatory network
We can construct the overall transcriptional regulatory network based on the estimated transcriptional regulatory interaction matrix. Figure 2 shows the estimated regulator network, which consists of 36 regulatory genes that have estimated transcriptional regulatory interactions with either themselves (i.e., autoregulation) or other regulators. The remaining 10 regulatory genes that are involved in the analysis but have no estimated transcriptional regulatory interactions with any regulators are not shown. Each of the 46 regulatory genes involved in the analysis has its own set of potential target genes, which are not shown in the graph neither to make it clear.
[ Figure 2 about here.]
The analysis results show that the proposed statistical approach is capable of identifying significant transcriptional regulatory interactions and the corresponding regulatory network structures. For example, the constructed network directly connects most of the regulators that are known to regulate the yeast cell cycle process, such as RME1, SWI4, SWI5, ACE2, MCM1, FKH1 and FKH2, to form a sub-network for cell cycle regulation. Among the estimated cell cycle related transcriptional regulatory interactions, some have already been experimentally confirmed. For example, ACE2 induces the meiosis repressor RME1 (Toone et al., 1995; McBride et al., 1999) ; REB1 directly increases the mRNA abundance of SWI5 (Svetlov and Cooper, 1995) ; FKH2 upregulates cell-cycle dependent expression of the CLB2 cluster of genes, which include SWI5 and ACE2 (Boros et al., 2003) .
The method is capable of revealing the transcriptional regulatory network structure that is not obvious under a single experiment condition. For example, our analysis suggests that SUM1 transcriptionally regulates NDT80, and NDT80 is auto-regulated. In fact, SUM1p and NDT80p bind competitively to the MSE sites in the promoter region of NDT80 and result in very different consequences: NDT80p activates the expression of NDT80, but SUM1p represses the expression of NDT80 (Pak and Segall, 2002) . The cross link between SUM1 and NDT80 may not be observed in a location analysis based on only one kind of growth condition.
Discussion
In this paper we described a causal inference model based approach for constructing transcriptional regulatory networks using data on gene expression, promoter sequence, and transcription factor binding sites. The method views an active transcription factor under a given experiment analogous to a point treatment and the gene expressions as responses. The concept of counterfactual gene expression is introduced and a marginal structural model is built for every gene and transcription factor pair to infer the regulatory interactions. Our simulation studies show that the overall error rate, false positive and false negative error rates in the estimated transcriptional regulatory networks are expected to be small or moderate if the systematic noise and the random error in the data is small and the sample size is moderately large. Our analysis based on 658 microarray experiments on yeast gene expression programs and 46 transcription factors suggests that the method is capable of identifying significant transcriptional regulatory interactions and uncovering the corresponding network structures.
The computational approach is based on available gene expression and sequence data, so it is time-wise and resource-wise more efficient than the experiment-based methods (e.g., location analysis). It is especially suitable for mining the fast accumulating microarray data on gene expressions under various experiment conditions. Since data from many different experiment conditions are explored, our method is particularly advantageous over location analysis and single transcription factor perturbation experiment based approaches for its capability of finding the transcriptional regulatory network structure that is not fully observable under a single experiment condition, for example, the interaction between SUM1 and NDT80.
As compared with our previous method (Xing and van der Laan, 2005) , this method is time-wise more efficient since it does not use the naive normal mixture model and the IPTW estimation of the marginal structural models is faster than the EM algorithm based estimation of the mixture models. But the MSM needs the no unmeasured confounders (NUC) assumption and the experimental treatment assignment (ETA) assumption to obtain consistent estimate of the causal effects. We usually are not able to check whether these assumptions all hold without further knowledge except for the data. The analysis based on data from real experiments seems to suggest that the two methods can be complementary to each other in maximizing significant findings.
The method has some the limitations. First, it may fail to estimate the regulatory interactions of a transcription factor that results in only subtle change in the genome-wide gene expression profile. Second, the method relies on knowledge of transcription factor binding sites. The number of transcription factors with known consensus binding sites is small and their functional coverage is somewhat limited. However, this may not be a problem when more and more transcription factor binding sites are characterized and added to our knowledge. Also, we may use putative transcription factor binding sites in the analysis. Using putative transcription factor binding sites will increase the error rates in estimation, but the constructed networks should suggest more models for further testing. 
